Streetbeat News

Regulatory

RCFA

Perception Capital Corp. IV has received a delinquency notice from the NYSE due to its failure to file a required quarterly report. This notice could impact the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:16 pm

DRCT

Direct Digital Holdings, Inc. received a delinquency notice from Nasdaq due to a delay in filing its Q2 Form 10-Q, risking non-compliance with Nasdaq's listing rules and potential delisting.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:14 pm

EWW

Mexican financial assets are under pressure due to a controversial judicial reform proposal, leading to a decline in the iShares MSCI Mexico ETF (EWW) and the Mexican peso. The reform, supported by President-elect Claudia Sheinbaum, faces criticism for potentially compromising judicial independence. Diplomatic tensions with the U.S. have risen, and rating agencies and investment banks have expressed concerns about the economic impact, with Morgan Stanley downgrading Mexico to Underweight.

Portfolio Pulse from Piero Cingari

August 27, 2024 | 8:10 pm

BYRN

Byrna Technologies has received legal approval for security professionals and private citizens in Mexico to carry Byrna launchers after completing a federally certified training program. This expansion follows successful operations in Canada and South America.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:09 pm

TPCS

TechPrecision Corporation has received a notice from Nasdaq for non-compliance due to a delayed filing of its quarterly report. The company has until September 16, 2024, to submit a compliance plan, with a possible extension to January 13, 2025. There is no immediate impact on its Nasdaq listing or trading.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:08 pm

MNPR

Monopar Therapeutics has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 8:06 pm

NVDA

Cryptocurrency markets, including Bitcoin, Ethereum, and Dogecoin, are experiencing a downturn as traders anticipate economic data releases and Nvidia's earnings. Despite the decline, Bitcoin's transaction volume and active addresses have surged, with many traders going long. The SEC is set to challenge Kraken, and Nasdaq seeks approval for Bitcoin index options.

Portfolio Pulse from Khyathi Dalal

August 27, 2024 | 8:06 pm

KARS

TSLA

Tesla shares are trading lower due to Canada's 100% tariff on Chinese EV imports, affecting Tesla's exports from its Shanghai factory. The EV sector faces trade tensions, stalling demand, and increased competition. Tesla's Cybertruck also faces negative publicity.

Portfolio Pulse from Vaishali Prayag

August 27, 2024 | 7:36 pm

ABBV

BMY

LLY

NBIX

The FDA is expected to approve a new schizophrenia drug from Karuna Therapeutics, recently acquired by Bristol Myers Squibb, on September 26. This innovative treatment aims to reduce severe side effects common in existing medications. The development marks a significant advancement in schizophrenia treatment, a field that hasn't seen new types of drugs in over 70 years.

Portfolio Pulse from Anthony Noto

August 27, 2024 | 7:22 pm

AVCNF

Avicanna Inc. has secured a US patent for its topical cannabinoid technology aimed at treating pain and inflammation. This technology, part of Avicanna's RHO Phyto portfolio, offers an alternative to traditional pain relief methods by delivering active ingredients directly into deep tissue layers, potentially providing better efficacy with fewer side effects.

Portfolio Pulse from Juan Spínelli

August 27, 2024 | 6:54 pm